Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease.

Pediatr Dermatol

Molecular Diagnostics Laboratory, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Published: August 2013

Porokeratosis is a rare disorder of epidermal keratinization that is regarded as a precancerous. Recipients of hematopoietic stem cell transplantation (HSCT) have a greater risk of skin cancer; chronic graft versus host disease (GVHD) is an additional risk factor. A 16-year-old boy who had received HSCT for acute myelogenous leukemia was referred to us for sclerodermoid chronic cutaneous GVHD. Two years later, he developed disseminated porokeratosis with a few atypical lesions. Despite cryotherapy, numerous lesions of porokeratosis recurred rapidly. Acitretin resulted in good clinical response and reduced the rate of onset of new lesions.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1525-1470.2011.01610.xDOI Listing

Publication Analysis

Top Keywords

chronic cutaneous
8
graft versus
8
versus host
8
host disease
8
efficacy acitretin
4
porokeratosis
4
acitretin porokeratosis
4
porokeratosis child
4
child chronic
4
cutaneous graft
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!